HKD 2.65
(-0.38%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.16 Billion CNY | 7.89% |
2022 | 1.07 Billion CNY | 4.65% |
2021 | 1.02 Billion CNY | 25.97% |
2020 | 816.25 Million CNY | 10.2% |
2019 | 740.67 Million CNY | 32.32% |
2018 | 559.76 Million CNY | 11.87% |
2017 | 500.37 Million CNY | 10.7% |
2016 | 452 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1.36 Billion CNY | 0.0% |
2023 Q4 | 1.16 Billion CNY | 0.0% |
2023 FY | 1.16 Billion CNY | 7.89% |
2023 Q2 | 1.14 Billion CNY | 0.0% |
2022 Q2 | 1.15 Billion CNY | 0.0% |
2022 FY | 1.07 Billion CNY | 4.65% |
2022 Q4 | 1.07 Billion CNY | 0.0% |
2021 FY | 1.02 Billion CNY | 25.97% |
2021 Q2 | 904.52 Million CNY | 0.0% |
2021 Q4 | 1.02 Billion CNY | 0.0% |
2020 FY | 816.25 Million CNY | 10.2% |
2020 Q4 | 816.25 Million CNY | 0.0% |
2020 Q2 | 867.83 Million CNY | 0.0% |
2019 Q4 | 740.67 Million CNY | 0.0% |
2019 Q2 | 684.41 Million CNY | 0.0% |
2019 FY | 740.67 Million CNY | 32.32% |
2018 Q4 | 559.76 Million CNY | 0.0% |
2018 FY | 559.76 Million CNY | 11.87% |
2017 FY | 500.37 Million CNY | 10.7% |
2016 FY | 452 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 229.69 Million HKD | -405.436% |
Lee & Man Chemical Company Limited | 1.22 Billion HKD | 5.554% |